Department of Orthopaedic Surgery, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Department of Orthopaedic Surgery, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Bone. 2019 Jul;124:22-32. doi: 10.1016/j.bone.2019.04.009. Epub 2019 Apr 15.
Debilitating stress fractures are surprisingly common in physically active individuals, including athletes, military recruits, and dancers. These individuals are overrepresented in the 30 million daily users of non-steroidal anti-inflammatory drugs (NSAIDs). We hypothesized that regular use of NSAIDs would predispose habitually loaded bones to stress fracture and delay the repair of these injuries. In this project, we used repetitive axial forelimb compression in mice as a model to test these hypotheses. First, adult mice were subjected to six bouts of forelimb compression over a period of two weeks, with aspirin, naproxen, or vehicle continuously administered through drinking water. Naproxen-treated mice had diminished load-induced bone formation as well as a significant loss in toughness in non-loaded bone, which were not observed in aspirin-treated mice. Furthermore, there were no differences in RANKL/OPG ratio or cortical bone parameters. Picrosirius red staining and second harmonic generation imaging revealed that alterations in bone collagen fibril size and organization were driving the loss of toughness in naproxen-treated mice. Separately, adult mice were subjected to an ulnar stress fracture generated by a single bout of fatigue loading, with NSAIDs provided 24 h before injury. Both aspirin-treated and naproxen-treated mice had normal forelimb use in the week after injury, whereas control mice favored the injured forelimb until day 7. However, woven bone volume was only significantly impaired by naproxen. Both NSAIDs were found to significantly inhibit Ptgs2 and Ngf expression following stress fracture, but only naproxen significantly affected serum PGE2 concentration. Overall, our results suggest that naproxen, but not aspirin, may increase the risk of stress fracture and extend the healing time of these injuries, warranting further clinical evaluation for patients at risk for fatigue injuries.
使人虚弱的应力性骨折在体力活动活跃的个体中相当常见,包括运动员、新兵和舞者。在每天使用 3000 万次非甾体抗炎药 (NSAIDs) 的人群中,这些人占比较高。我们假设,经常使用 NSAIDs 会使习惯性受力的骨骼易患应力性骨折,并延迟这些损伤的修复。在这个项目中,我们使用小鼠重复轴向前肢压缩作为模型来测试这些假设。首先,成年小鼠在两周的时间内接受了六次前肢压缩,阿司匹林、萘普生或载体通过饮用水持续给药。萘普生治疗的小鼠负荷诱导的骨形成减少,非负荷骨的韧性显著丧失,而阿司匹林治疗的小鼠则没有观察到这两种情况。此外,RANKL/OPG 比值或皮质骨参数没有差异。苦味酸红染色和二次谐波成像显示,骨胶原纤维大小和组织的改变是导致萘普生治疗的小鼠韧性丧失的原因。另外,成年小鼠通过单次疲劳加载产生尺骨应力性骨折,在损伤前 24 小时给予 NSAIDs。阿司匹林治疗和萘普生治疗的小鼠在受伤后一周内仍能正常使用前肢,而对照组小鼠在受伤后 7 天内仍偏好使用受伤的前肢。然而,只有萘普生显著损害了编织骨体积。两种 NSAIDs 在应力性骨折后均显著抑制 Ptgs2 和 Ngf 的表达,但只有萘普生显著影响血清 PGE2 浓度。总的来说,我们的结果表明,萘普生而不是阿司匹林可能会增加应力性骨折的风险,并延长这些损伤的愈合时间,这需要对有疲劳损伤风险的患者进行进一步的临床评估。